This thesis provides an overview of the results of contemporaneous revascularisation strategies in patients with three-vessel (3VD) and/or left main coronary artery disease (LMCAD). We sought to distinguish treatment benefits and risk predictors for short-term (<1 year), mid-term (1 – 3 year) and long-term (≥10 year) follow-up in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The impact of patients comorbidities, the use of multiple arterial grafting and 3VD versus LMCAD was assessed. Moreover, we have updated a risk score to estimate the risk of 10-year all-cause death in patients with complex coronary artery disease undergoing PCI or CABG. Finally, we assessed the impact of using intraoperative quality assessment tools during CABG that could further improve surgical and patient-related outcomes.
Our studies have been published in well-known international scientific journals such as The Lancet, The European Heart Journal, The Journal of Thoracic CardioVascular Surgerey and the European Journal of CardioThoracic Surgery.

, , , , , , , , , , , , ,
A.P. Kappetein (Arie Pieter)
Erasmus University Rotterdam
Department of Cardio-Thoracic Surgery

Thuijs, D.J.F.M. (2021, January 26). Improving Clinical Outcomes After Contemporaneous Myocardial Revascularisation Strategies: Percutaneous Coronary Intervention (PCI) versus Coronary Artery Bypass Grafting (CABG). Erasmus University Rotterdam. Retrieved from